全文获取类型
收费全文 | 525篇 |
免费 | 36篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 20篇 |
妇产科学 | 3篇 |
基础医学 | 70篇 |
口腔科学 | 3篇 |
临床医学 | 32篇 |
内科学 | 145篇 |
皮肤病学 | 21篇 |
神经病学 | 25篇 |
特种医学 | 7篇 |
外科学 | 85篇 |
综合类 | 6篇 |
预防医学 | 23篇 |
眼科学 | 1篇 |
药学 | 33篇 |
中国医学 | 2篇 |
肿瘤学 | 84篇 |
出版年
2023年 | 6篇 |
2022年 | 4篇 |
2021年 | 11篇 |
2020年 | 1篇 |
2019年 | 3篇 |
2018年 | 7篇 |
2017年 | 10篇 |
2016年 | 10篇 |
2015年 | 13篇 |
2014年 | 16篇 |
2013年 | 26篇 |
2012年 | 35篇 |
2011年 | 48篇 |
2010年 | 27篇 |
2009年 | 26篇 |
2008年 | 31篇 |
2007年 | 33篇 |
2006年 | 24篇 |
2005年 | 27篇 |
2004年 | 31篇 |
2003年 | 25篇 |
2002年 | 38篇 |
2001年 | 8篇 |
2000年 | 4篇 |
1999年 | 10篇 |
1998年 | 5篇 |
1997年 | 11篇 |
1996年 | 3篇 |
1995年 | 4篇 |
1994年 | 3篇 |
1993年 | 4篇 |
1992年 | 6篇 |
1991年 | 9篇 |
1990年 | 6篇 |
1989年 | 3篇 |
1988年 | 1篇 |
1987年 | 2篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1984年 | 3篇 |
1983年 | 4篇 |
1980年 | 2篇 |
1975年 | 1篇 |
1974年 | 3篇 |
1970年 | 2篇 |
1969年 | 4篇 |
1968年 | 3篇 |
1967年 | 1篇 |
1966年 | 2篇 |
1956年 | 1篇 |
排序方式: 共有562条查询结果,搜索用时 19 毫秒
1.
Hiroto Kayashima Ken Shirabe Rumi Matono Shohei Yoshiya Kazutoyo Morita Kenji Umeda Toru Ikegami Tomoharu Yoshizumi Yuji Soejima Yoshihiko Maehara 《Surgery today》2014,44(11):2077-2085
Purpose
To evaluate the anatomical variations in the middle hepatic vein tributaries (V5/V8) for determining the reconstruction strategy in right lobe living donor liver transplantation (LDLT).Methods
The V5/V8 variations were examined in 268 patients and were classified into three and two types, respectively. The reconstruction rate (RR), patency rate (PR) and clinical outcomes were retrospectively evaluated in 46 right lobe LDLT cases.Results
In terms of V5 variations, the RR and PR were significantly higher for type 2 than type 3 (82.6 vs. 44.4 % and 73.7 vs. 25.0 %, respectively). The alanine aminotransferase level on postoperative day (POD) 5 in the V5 patent group was significantly lower than in the occluded group (123 vs. 191 IU/dL). Regarding V8 variations, the RR and PR were significantly higher for type 1 than type 2 (44.4 vs. 17.6 % and 75.0 vs. 33.3 %, respectively). The aspartate aminotransferase level on POD 3 was significantly lower in the V8 patent group than in the occluded group (50 vs. 121 IU/dL).Conclusion
For right lobe grafts with single large V5 (type 2) or V8 (type 1) variations, reconstruction is necessary. Our new classification of the MHV tributaries is useful for determining the reconstruction strategy to use in right lobe LDLT. 相似文献2.
3.
Sadaoki Sakai Miho Suzuki Yoshihito Tashiro Keisuke Tanaka Satoshi Takeda Ken Aizawa Michinori Hirata Kenji Yogo Koichi Endo 《Journal of bone and mineral research》2015,30(1):128-136
Bone fractures markedly reduce quality of life and life expectancy in elderly people. Although osteoporosis increases bone fragility, fractures frequently occur in patients with normal bone mineral density. Because most fractures occur on falling, preventing falls is another focus for reducing bone fractures. In this study, we investigated the role of vitamin D receptor (VDR) signaling in locomotive ability. In the rotarod test, physical exercise enhanced locomotive ability of wild‐type (WT) mice by 1.6‐fold, whereas exercise did not enhance locomotive ability of VDR knockout (KO) mice. Compared with WT mice, VDR KO mice had smaller peripheral nerve axonal diameter and disordered AChR morphology on the extensor digitorum longus muscle. Eldecalcitol (ED‐71, ELD), an analog of 1,25(OH)2D3, administered to rotarod‐trained C57BL/6 mice enhanced locomotor performance compared with vehicle‐treated nontrained mice. The area of AChR cluster on the extensor digitorum longus was greater in ELD‐treated mice than in vehicle‐treated mice. ELD and 1,25(OH)2D3 enhanced expression of IGF‐1, myelin basic protein, and VDR in rat primary Schwann cells. VDR signaling regulates neuromuscular maintenance and enhances locomotive ability after physical exercise. Further investigation is required, but Schwann cells and the neuromuscular junction are targets of vitamin D3 signaling in locomotive ability. © 2014 American Society for Bone and Mineral Research. 相似文献
4.
The biphasic effect of extracellular glucose concentration on carbachol‐induced fluid secretion from mouse submandibular glands 下载免费PDF全文
Momomi Terachi Chikara Hirono Michinori Kitagawa Makoto Sugita 《European journal of oral sciences》2018,126(3):197-205
Cholinergic agonists evoke elevations of the cytoplasmic free‐calcium concentration ([Ca2+]i) to stimulate fluid secretion in salivary glands. Salivary flow rates are significantly reduced in diabetic patients. However, it remains elusive how salivary secretion is impaired in diabetes. Here, we used an ex vivo submandibular gland perfusion technique to characterize the dependency of salivary flow rates on extracellular glucose concentration and activities of glucose transporters expressed in the glands. The cholinergic agonist carbachol (CCh) induced sustained fluid secretion, the rates of which were modulated by the extracellular glucose concentration in a biphasic manner. Both lowering the extracellular glucose concentration to less than 2.5 mM and elevating it to higher than 5 mM resulted in decreased CCh‐induced fluid secretion. The CCh‐induced salivary flow was suppressed by phlorizin, an inhibitor of the sodium–glucose cotransporter 1 (SGLT1) located basolaterally in submandibular acinar cells, which is altered at the protein expression level in diabetic animal models. Our data suggest that SGLT1‐mediated glucose uptake in acinar cells is required to maintain the fluid secretion by sustaining Cl? secretion in real‐time. High extracellular glucose levels may suppress the CCh‐induced secretion of salivary fluid by altering the activities of ion channels and transporters downstream of [Ca2+]i signals. 相似文献
5.
One‐year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases 下载免费PDF全文
Akiko Yagami Masutaka Furue Michinori Togawa Akihiro Saito Michihiro Hide 《The Journal of dermatology》2017,44(4):375-385
A number of second‐generation non‐sedating antihistamines are used in clinical practices over the world. However, long‐term safety and efficacy have not been proved high level evidence based medicine. We have performed an open‐label, multicenter, phase III study to evaluate the long‐term safety and efficacy of bilastine, a novel non‐sedating H1‐antihistamine for patients with chronic spontaneous urticaria (CSU) or pruritus associated with skin diseases (trial registration no. JapicCTI‐142528). Patients aged 18–74 years were treated with bilastine 20 mg once daily for up to 52 weeks. Safety and tolerability were assessed on the basis of adverse events (AE), bilastine‐related AE, laboratory tests and vital signs. Efficacy was assessed based on rash score, itch score, overall improvement and quality of life. One hundred and ninety‐eight patients enrolled, 122 of whom (61.6%) completed the 52‐week treatment period. AE were reported in 64.5% and bilastine‐related AE in 2.5% of patients throughout the 52‐week treatment period. All AE were mild to moderate in severity. AE associated with the nervous system occurred in 10 patients (5.1%) including seven patients (3.6%) with headache. Somnolence reported in two of these patients (1.0%) was related to bilastine. All efficacy variables improved during treatment with bilastine. In conclusion, long‐term treatment with bilastine 20 mg once daily for 52 weeks is safe and well tolerated in Japanese patients with CSU or pruritus associated with skin diseases. Bilastine improved disease symptoms of both conditions early in treatment, and the efficacy was maintained throughout the treatment. 相似文献
6.
Yoshihiro Matsumoto Toru Ikegami Kazutoyo Morita Tomoharu Yoshizumi Hiroto Kayashima Ken Shirabe Yoshihiko Maehara 《Surgery today》2013,43(11):1316-1320
End-stage liver disease is often accompanied by thrombosis of the portal vein and the formation of splanchnic collateral vessels. Successful liver transplantation in such situations is more likely if the surgeon uses a strategy to establish a graft inflow. A 59-year-old male with a decompensated liver secondary to idiopathic portal hypertension underwent living donor liver transplantation (LDLT) using a right lobe liver graft donated from his son. His portal venous trunk was atrophied and a splenorenal shunt drained the mesenteric venous flow into the systemic circulation. LDLT was performed with renoportal anastomosis (RPA) using his right internal jugular vein as an interposed venous graft, without dissecting the collateral vessels. Although he developed temporary functional hyperbilirubinemia, he was discharged from the hospital 23 days after LDLT. This case suggests that RPA is a useful technique to manage patients with an obstructed portal vein and a splenorenal shunt. 相似文献
7.
8.
9.
10.